Therapy News and Research

RSS

First-in-human study of DBS for post-stroke rehabilitation shows encouraging results

Targeting the dentate nucleus with deep brain stimulation (DBS) was safe and feasible for promoting post-stroke rehabilitation in a first-in-human study at Cleveland Clinic.

21 Oct 2021

Study offers clues to why calorie-restricted diet may slow tumor growth

In recent years, there has been some evidence that dietary interventions can help to slow the growth of tumors.

20 Oct 2021

Study investigates whether continued magnetic seizure therapy can prevent relapse of depression

Treatment-resistant depression or TRD is exactly what it sounds like: a form of mental illness that defies effective therapy. It is not rare, with an estimated 3 million persons in the United States suffering from TRD.

20 Oct 2021

The neutralization potential of nanobodies against SARS-CoV-2

A recent review describes the role of nanobodies as a new class of recombinant antibodies that are used in the treatment of COVID-19.

20 Oct 2021

Research may lead to breakthroughs in combating cancer drug resistances

New research has revealed the differences in mechanism behind cancer’s resistance to the major class of anti-cancer drugs known as nucleoside analogues.

20 Oct 2021

Cat bacteria likely to form the basis for novel therapeutics against severe skin infections

Researchers at University of California San Diego School of Medicine used bacteria found on healthy cats to successfully treat a skin infection on mice. These bacteria may serve as the basis for new therapeutics against severe skin infections in humans, dogs and cats.

20 Oct 2021

Researchers identify new gene variants that may cause inherited retinal dystrophies

An international team of researchers, led by scientists at University of California San Diego and Shiley Eye Institute at UC San Diego Health, has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.

20 Oct 2021

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

A clinical study by a team of scientists from Norway aimed to assess the immunogenicity and safety of a third dose of COVID-19 mRNA vaccine in MS patients treated with anti-CD20 therapy or fingolimod. A preprint version of the study, which is yet to undergo peer review, is available on the medRxiv* server.

20 Oct 2021

New technology streamlines the development of gene therapy for genetic blinding disorders

A novel computational platform developed by researchers from the University of Pittsburgh School of Medicine identifies top-performing viral vectors that could deliver gene therapies to the retina with maximum efficiency and precision.

19 Oct 2021

Infrared light therapy may potentially benefit people with dementia

Infrared light therapy might have the potential to help people living with dementia, according to researchers.

19 Oct 2021

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.

19 Oct 2021

Study reveals potential new approach to fight urinary tract infections

Identifying the dynamic events occurring during urinary tract infections (UTI) has revealed a new potential strategy to combat this condition, considered the most common type of infection.

19 Oct 2021

Lactoferrin supplements could be used as adjunct for COVID-19 and other respiratory tract infections

The antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a team of researchers led by the University of Huddersfield.

19 Oct 2021

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.

19 Oct 2021

COVID-19 vaccine breakthrough infections among immunocompromised individuals

A study of breakthrough infections in immunocompromised people following two doses of the Pfizer/BioNTech vaccine against SARS-CoV-2 concluded that immunocompromised people would be best served with a third dose of the vaccine for better protection.

19 Oct 2021

Factors impacting mental health and wellbeing of long covid patients

A new preprint deals with the mental baggage accompanying this condition, often termed “long covid.”

19 Oct 2021

New system for targeted cancer radiation therapy using gold nanoparticles

Scientists from the Department of Nuclear Medicine and Tracer Kinetics at Osaka University developed a novel system for targeted cancer radiation therapy that uses gold nanoparticles labeled with astatine-211.

19 Oct 2021

Rewarming after cooling therapy increases the odds of seizures in oxygen-deprived newborns

Oxygen-deprived newborns who undergo cooling therapy to protect their brains are at an elevated risk of seizures and brain damage during the rewarming period, which could be a precursor of disability or death, a new study by a team of researchers led by a UT Southwestern pediatrician suggests.

19 Oct 2021

Researchers reveal the mechanism of artificial chromosome formation in C. elegans' embryos

A research team led by Dr Karen Wing Yee YUEN, Associate Professor from the School of Biological Sciences at the University of Hong Kong (HKU), revealed the mechanism of artificial chromosome (AC) formation in the embryos of the model organism Caenorhabditis elegans, a 1-mm long, transparent nematode.

18 Oct 2021

Researchers illustrate the importance and value of sharing negative research results

In the era of "publish or perish," research results that disprove the hypothesis tested often go unpublished. In addition, many researchers who have been unable to reproduce results from other laboratories have found it difficult to publish their findings.

18 Oct 2021

Therapy News and Research

First-in-human study of DBS for post-stroke rehabilitation shows encouraging results

Study offers clues to why calorie-restricted diet may slow tumor growth

Study investigates whether continued magnetic seizure therapy can prevent relapse of depression

The neutralization potential of nanobodies against SARS-CoV-2

Research may lead to breakthroughs in combating cancer drug resistances

Cat bacteria likely to form the basis for novel therapeutics against severe skin infections

Researchers identify new gene variants that may cause inherited retinal dystrophies

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

New technology streamlines the development of gene therapy for genetic blinding disorders

Infrared light therapy may potentially benefit people with dementia

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

Study reveals potential new approach to fight urinary tract infections

Lactoferrin supplements could be used as adjunct for COVID-19 and other respiratory tract infections

UQ start-up secures $1.3 million seed investment to develop new treatment for liver disease

COVID-19 vaccine breakthrough infections among immunocompromised individuals

Factors impacting mental health and wellbeing of long covid patients

New system for targeted cancer radiation therapy using gold nanoparticles

Rewarming after cooling therapy increases the odds of seizures in oxygen-deprived newborns

Researchers reveal the mechanism of artificial chromosome formation in C. elegans' embryos

Researchers illustrate the importance and value of sharing negative research results

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News